How many shares did cancer genetics own after the merger?

Immediately after the merger, there were approximately 28,984,458 million shares of Common Stock of the Company outstanding. H.C. Wainwright & Co. acted as financial advisor to Cancer Genetics, Inc., and Lowenstein Sandler LLP served as legal counsel to Cancer Genetics.

What does cancer genetics do?

Cancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services and molecular markers. Through its subsidiary, the Company offers preclinical test systems.

Where is cancer genetics headquartered?

The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ. Sign-up to receive the latest news and ratings for Cancer Genetics and its competitors with MarketBeat's FREE daily newsletter. MarketBeat has just released its list of 20 stocks that Wall Street analysts hate.